Should I use a blood test to diagnose genital warts (condyloma acuminata) and herpes simplex virus infection, or are lesion PCR tests preferred?

Blood Tests Are NOT Used for Genital Warts; PCR from Lesions is Preferred for Herpes Diagnosis

Genital Warts (Condyloma Acuminata)

There is no blood test for genital warts—diagnosis is clinical, and when confirmation is needed, tissue biopsy with histopathology is the appropriate test, not serology. 1

Genital warts are caused by low-risk HPV types (primarily HPV 6 and 11) and are diagnosed by:

• Visual inspection of characteristic papillary or cauliflower-like lesions
• Biopsy with histopathology when the diagnosis is uncertain or lesions are atypical 2
• PCR testing may be performed on excised tissue in select cases (persistent lesions, atypical appearance, or concern for high-risk HPV co-infection), but this is investigational and does not change routine management 2

Key pitfall: Do not order HPV blood tests for genital warts—they do not exist for diagnostic purposes. HPV serology is not clinically useful for diagnosing active infection.

---

Genital Herpes (HSV)

When Lesions Are Present

PCR from the lesion is the test of choice for diagnosing genital herpes when active lesions are present—it has >90% sensitivity and specificity and should differentiate HSV-1 from HSV-2. 3

The diagnostic hierarchy when lesions are present:

1. HSV PCR/NAAT from lesion swab (preferred) 3, 4, 5

   • Collect from intact vesicles or early ulcers for highest yield 6
   • Substantially more sensitive than viral culture (24% higher detection rate) 5
   • Must type-specify (HSV-1 vs HSV-2) for prognostic counseling 3

2. Viral culture (acceptable if PCR unavailable due to cost/access) 3

   • Less sensitive, especially as lesions heal
   • If negative but HSV still suspected, follow with serology 3

3. Direct immunofluorescence and Tzanck smear are NOT recommended due to poor sensitivity 3

Critical timing: Yield decreases as lesions heal; test early in the course of outbreak 3, 7

---

When No Lesions Are Present

Type-specific HSV serology (IgG antibodies to glycoprotein G) is the appropriate test when no active lesions are present but there is clinical suspicion of genital herpes. 3, 8

Important limitations of HSV serology:

• HSV-1 IgG has poor sensitivity (only 70.2%)—may miss true infections 3
• HSV-2 IgG has poor specificity at low index values:
  • Index 1.1-2.9: only 39.8% specificity
  • Index ≥3.0: 78.6% specificity
  • False positives are common, especially in HSV-1 positive patients 3

Do NOT use HSV IgM—it is useless for diagnosis of genital herpes 7

Do NOT swab genital areas in the absence of lesions—intermittent viral shedding makes this insensitive 3

---

Specific Clinical Scenarios for Serology

Type-specific serology is indicated for:

• Patients with suspected genital herpes but negative PCR/culture from lesions 3, 8
• Asymptomatic patients with history suggestive of genital herpes 8
• HIV-infected patients 8
• Evaluation of HSV-discordant couples 8
• Pregnant women with first clinical episode during pregnancy (combined with PCR to distinguish primary from non-primary first episode) 7
• Asymptomatic pregnant women whose partners have genital herpes 8

Universal screening during pregnancy is NOT recommended 7

---

Algorithm Summary

For Genital Warts:

• Clinical diagnosis by visual inspection
• Biopsy only if atypical or uncertain
• No blood test exists

For Genital Herpes:

• Lesions present → HSV PCR from lesion (preferred) or culture if PCR unavailable
• No lesions, but clinical suspicion → Type-specific HSV-2 IgG serology (interpret cautiously based on index value)
• Never use IgM or swab without lesions

The fundamental distinction: Genital warts have no serologic test; herpes diagnosis depends on whether lesions are present (PCR preferred) or absent (serology indicated). 3, 1